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published December 2, 2009; doi:10.1152/ajprenal.00413.2009.—
Noninvasive analysis of renal function in conscious mice is necessary
to optimize the use of mouse models. In this study, we evaluated
whether single photon emission-computed tomography (SPECT) us-
ing specific radionuclear tracers can be used to analyze changes in
renal proximal tubule functions. The tracers included 99mTC- dimer-
captosuccinic acid (99mTc-DMSA), which is used for cortex imaging;
99mTc-mercaptoacetyltriglycine (99mTc-MAG3), used for dynamic
renography; and 123I-2-microglobulin, which monitors receptor-me-
diated endocytosis. 99mTc-DMSA SPECT imaging was shown to
delineate the functional renal cortex with a 1-mm spatial resolution
and accumulated in the cortex reaching a plateau 5 h after injection.
The cortical uptake of 99mTc-DMSA was abolished in Clcn5 knockout
mice, a model of proximal tubule dysfunction. Dynamic renography
with 99mTc-MAG3 in conscious mice demonstrated rapid extraction
from blood, renal accumulation, and subsequent tubular secretion.
Anesthesia induced a significant delay in the 99mTc-MAG3 clearance.
The tubular reabsorption of 123I-2-microglobulin was strongly im-
paired in the Clcn5 knockout mice, with defective tubular processing
and loss of the native tracer in urine, reflecting proximal tubule
dysfunction. Longitudinal studies in a model of cisplatin-induced
acute tubular injury revealed a correlation between tubular recovery
and 123I-2-microglobulin uptake. These data show that SPECT
imaging with well-validated radiotracers allows in vivo investigations
of specific proximal tubule functions in conscious mice.
receptor-mediated endocytosis; tubular secretion; ClC-5; Dent’s dis-
ease; radionuclear tracers
TRANSGENIC MOUSE STRAINS ARE widely used to investigate the
structure and function of developing and mature kidneys and to
model human disorders. Thus far, functional studies into dis-
ease mechanisms essentially require animal death and ex vivo
investigations that are potentially limited by various factors
including low fertility rates, gender effects (e.g., X-linked
transmission), or limited life span in some models. These
restrictions complicate the design of intervention studies and
require the development of large colonies, increasing costs and
raising ethical questions. To circumvent some of these limita-
tions, efforts are being made to develop in vivo functional
imaging techniques in mice. In particular, the possibility to
perform quantitative and/or dynamic molecular imaging stud-
ies using high-resolution positron emission tomography (PET)
or single photon emission-computed tomography (SPECT) has
emerged recently (23).
Among its numerous applications, SPECT may be useful for
noninvasive investigation of renal function in the mouse by
means of dynamic imaging, parenchymal scanning, and quan-
tification of filtration, secretion, and reabsorption events (8). In
particular, the possibility to use different radiotracers for
SPECT imaging provides the opportunity to investigate vari-
ous transport processes taking place in the proximal tubule
(PT), a segment that plays a paramount role in homeostasis
(Fig. 1). Diseases causing PT dysfunction are associated with
life-threatening complications, including electrolyte and acid-
base disorders, protein and amino acid imbalance, as well as
abnormal handling of numerous endogenous and exogenous
compounds.
To evaluate the technical possibilities of dynamic molecular
imaging in vivo, we have used a SPECT system (26) to
investigate the transport functions of the PT including apical
and basolateral uptake and apical secretion. We evaluated these
parameters in control mice, mice with restricted kidney infarc-
tion, and mice with congenital or acquired PT dysfunction
(renal Fanconi syndrome). In particular, we used Clcn5 knock-
out (KO; Clcn5Y/) mice that are characterized by generalized
PT dysfunction and low-molecular-weight (LMW) proteinuria
due to defective receptor-mediated endocytosis (7) and repre-
sent a well-established model for Dent’s disease (28). We also
used a mouse model of acquired, reversible PT injury induced
by cisplatin (9) to evaluate the potential recovery over time.
To avoid the potential deleterious effects of general anes-
thesia, SPECT imaging was performed in conscious mice,
using three well-established renal radionuclear tracers (Fig. 1).
99mTc-mercaptoacetyltriglycine (99mTc-MAG3), which is se-
creted into the urine following basolateral uptake by PT cells,
is regarded as the best available tubular marker for dynamic
renography (12). Dimercaptosuccinic acid (99mTc-DMSA),
which accumulates in the renal cortex by a basolateral uptake
in the epithelial cells lining the pars recta (S3 segment), is used
for cortex imaging (16, 25). Finally, 123I-2-microglobulin is a
reference tracer for assessing the receptor mediated endocyto-
sis of ultrafiltered LMW proteins by PT cells (7).
MATERIALS AND METHODS
Animals. Experiments were conducted on 12- to 20-wk-old C57/
BL6 (body wt: 25–30 g) and matched pairs of Clcn5 wild-type
(Clcn5Y/) and KO (Clcn5Y/) littermates. The Clcn5Y/ mice have
been extensively characterized (28) and had similar body weight,
hematocrit, and plasma creatinine levels than wild-type littermates in
this age group. Restricted kidney infarction was induced in C57 mice
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by clamping the superior pole of the organ for 30 min under anesthe-
sia. A model of partial or full recovery of acute PT injury was
obtained by a single injection of either vehicle (saline) or cisplatin (12
mg/kg BW ip) in C57 mice with follow-up for 2 wk (9). Mice were
housed individually in metabolic cages to assess overnight urine flow
rate and renal function during the cisplatin protocol. All procedures
were performed in accordance with National Institutes of Health
guidelines for the care and use of laboratory animals, and with the
approval of the Committee for Animal Rights of the Université
catholique de Louvain Medical School.
Radiotracers. Human 2-microglobulin (2M; Sigma, St. Louis,
MO) was iodinated with 123I-Na (GE Healthcare, Brussels, Bel-
gium) and Iodobeads (Pierce, Aalst, Belgium) as previously described
(7) (purity in excess of 92% trichloroacetic acid-precipitable). Dimer-
captosuccinic acid (TechneScan DMSA) or mercaptoacetyltriglycine
(TechneScan MAG3) from Tyco HealthCare (Mechelen, Belgium)
were radiolabeled with 99mTc-Na-pertechnetate (Tyco HealthCare)
following the standard procedure. The physical half-life of 123I is 13
h and that of 99mTc is 6 h. Radiopharmaceutical purity was 99%, as
confirmed by instant thin-layer chromatography. All radiotracers were
diluted in saline (NaCl 0.9%) and injected (lateral caudal vein of the
tail iv) in a total volume of 150 l.
SPECT system. The small-animal SPECT device (Linoview Sys-
tems, Amsterdam, The Netherlands) is made of four -detectors based
on pixilated CsI(Na) scintillators (5-mm thickness, 2.44  2.44-mm
crystal size). Detectors are fitted with a rake collimator equipped with
an adjustable slit aperture, made of two iridium square rods (2  2 
60-mm) (Supplemental Fig. 1; all supplementary material for this
article is available on the journal web site). The spatial resolution of
the system after reconstruction is 0.35 mm (26).
Acquisition procedure. In a preliminary experiment, dynamic
99mTc-MAG3 SPECT imaging was performed before and after anes-
thesia (ketamine, 100 g/g, Merial, Brussels, Belgium; xylazine 10
g/g, Bayer, Antwerp, Belgium) in two pairs of C57 mice. Subse-
quently, kinetic studies with the three radiotracers were performed on
conscious Clcn5 mice placed in a plastic holder to reduce animal
motion during imaging (Supplemental Fig. 1). The mice (pairs of
Clcn5 WT vs. KO) were studied over a total period of 8 wk, with three
sequential injections of DMSA, MAG3, and 2M on the same mice,
separated by a minimal interval of 5 days.
Static SPECT was obtained hourly (acquisitions of 5 min each)
during 5 h after intravenous (iv) injection of 700 Ci of 99mTc-DMSA
(n 	 4 pairs). At 6 h postinjection, a 30-min acquisition was per-
formed under anesthesia to obtain high-resolution images. In two pairs
of mice, the scanning was repeated 30 min after furosemide injection
(10 mg/kg BW ip; final volume: 30 l). Continuous dynamic SPECT
(acquisitions of 15-s each) was achieved over 30 min after iv injection
of 600 Ci of 99mTc-MAG3 (n 	 3 pairs) or 200 Ci 123I-2-
microglobulin (n 	 3 pairs), respectively. The linear motion of the
detectors was set in such a way that the four-slit apertures would draw
the narrowest rectangle possible around the animal. The distance
between the actual contours and the collimator aperture was typically
Fig. 1. Transport of 2-microglobulin (2M), mercaptoacetyltriglycine (MAG3), and dimercaptosuccinic acid (DMSA) along the proximal tubule (PT). The
epithelial cells lining the convoluted part (S1–S2 segments) of the PT efficiently reabsorb the low-molecular-weight 2M from the primitive urine (glomerular
ultrafiltrate) by receptor-mediated endocytosis after interaction with the multiligand receptors megalin and cubilin. After internalization and progression along
the endocytic apparatus (E), 2M is degraded in lysosomes (L). In addition, PT cells secrete MAG3 from the plasma into the urine. The basolateral uptake of
MAG3 occurs in exchange for intracellular dicarboxylates, namely, 
-ketoglutarate (
-KG), through the organic anion transporter OAT1 (SLC22A6). A-KG is
a key intermediate in the Krebs cycle, which enters PT cells through a Na-dicarboxylate cotransporter (NaDC; not formally identified as NaDC3; see below),
whereas Na is recycled through the Na-K-ATPase. The MAG3 secretion into the lumen is mediated by the multidrug resistance protein MRP2 inserted in
the apical membrane of PT cells. The Na-dependent phosphate transporter NPT1 may also be involved in MAG3 secretion. The epithelial cells lining the pars
recta (S3 segment) of the PT are involved in the basolateral uptake of DMSA from peritubular capillaries, which is mediated by the Na-dicarboxylate cotransporter
NaDC3 (also named SLC13A3). A limited fraction of DMSA is filtered through the glomerulus and lost in the urine. Modified from Refs. 4 and 24.
F455SPECT IMAGING IN MOUSE KIDNEY











3 mm. The linear acquisition generates linograms forming a com-
plete set of tomographic data allowing the reconstruction of the
activity map (27).
Data processing. Reconstructions were performed using the max-
imum-likelihood expectation maximization algorithm with attenua-
tion correction but without scatter correction or spatial resolution
recovery (11). Time-activity curves were generated. 99mTc-MAG3
dynamic parameters were calculated using a three-compartment
model, by fitting the curves to two exponentials.
The glomerular filtration rate (GFR) of 123I-2-microglobulin was
assessed by fitting all the organ curves (heart, kidney, thyroid, liver,
spleen, bladder) by a multicompartmental model (Supplemental Fig.
2). The GFR can be calculated as GFR 	 kg
1Vp (i), where kg
1 is the
glomerular uptake rate of the 123I-2-microglobulin, and Vp is the
plasma volume. Only the interval from 30 to 180 s postinjection was
considered to avoid the effects of dilution after bolus injection, as well
as 123I-2-microglobulin tubular reabsorption and metabolization,
respectively. All kinetic parameters of renal uptake were calculated
using SigmaPlot 2000 (Systat Software, Erkrath, Germany). The
plasma volume of the mice was estimated based on blood volume (8%
body wt) (20) and 0.45 as average hematocrit value for the Clcn5
mice.
Autoradiography. For autoradiography, kidneys were exsanguined
in situ, removed 7 min after iv injection of 620 ng/g of body weight
of 125I-2-microglobulin, and fixed for 6 h at 4°C in 4% formalde-
hyde. Ten-micrometer sections were overlaid, treated with emulsion
reagent (Ilford Scientific Product, Wilrijk, Belgium), and revealed
after 1 mo.
Plasma and urine analyses. Urinary creatinine (modified Jaffé
method) and albumin (turbimetric method) and plasma creatinine
(enzymatic determination) were measured on a Synchron CX5 ana-
lyzer (Beckman Coulter, Brea, CA), following the manufacturer’s
protocols (3). The urinary excretion of the LMW Clara cell protein
(CC16, 16 kDa) was measured by radioimmunoassay (7).
Statistics. Results are expressed as means  SD. Comparisons
between Clcn5Y/ and Clcn5Y/ mice were made by Student’s
unpaired t-tests assuming equal variance. The significance level was
set at P  0.05. Interassay variability was calculated as variation
coefficient in 6 kidneys.
RESULTS
Imaging of the kidney cortex based on static 99mTc-DMSA
uptake. 99mTc-DMSA is regarded as the ideal tracer for cortical
imaging of the kidney. After uptake through the basolateral
membrane, 99mTc-DMSA remains firmly bound to PT cells.
We first investigated the spatial resolution of 99mTc-DMSA
SPECT imaging of the kidney in wild-type (C57) mice. At 5 h
postinjection, 99mTc-DMSA SPECT clearly delineated the
functional renal cortex, whereas the medulla and the pelvis
area (1 mm) remained silent (Fig. 2A). The tracer uptake was
Fig. 2. Single photon emission-computed to-
mography (SPECT) imaging of 99mTc-DMSA
in mouse: perfusion (kidney infarction) and
functional (Clcn5 inactivation) defects. A and
B: 99mTc-DMSA SPECT (A) in wild-type mice
after apical infarction of the right kidney (R).
Coronal (top) and transverse (bottom) slices
show no activity in the infarction area (arrow-
heads). Bars	 3 mm. Histological examination
after hematoxylin-eosin staining (B) confirms
the infarction of the top right pole of the corre-
sponding kidney (low magnification, top; high
magnification, bottom). Bars	 3 mm (top) and
100 m (bottom). C: kinetics of 99mTc-DMSA
uptake in the kidney cortex measured using
consecutive SPECT acquisitions (n 	 8 kid-
neys from 4 mice). The asymptotic curve was
fitted on the mean (red circle), and supports
equilibrium (9.8  0.4% of injected dose) at 5
h postinjection in Clcn5Y/ mice. SD is repre-
sented at each time point. Renal uptake of
99mTc-DMSA is abolished in Clcn5Y/ mice
(n 	 8 kidneys, blue square). D and E: repre-
sentative coronal (D) and transverse (E) sec-
tions of 99mTc-DMSA SPECT imaging of
Clcn5Y/ and Clcn5Y/ kidneys (6 h postinjec-
tion), before and after furosemide administra-
tion (10 mg/kg body wt ip). In Clcn5Y/ kid-
neys, the tracer is concentrated over the cortex
area and insensitive to furosemide administra-
tion. In Clcn5Y/ mice, the 99mTc-DMSA sig-
nal is minimal, exclusively located in the pelvis,
and rapidly cleared after furosemide injection.
Dotted circles represent the cortical contours in
Clcn5Y/ kidneys. Bars 	 3 mm.
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abolished over an apical area of experimental infarction, the
boundaries of which correlated with the histopathological ex-
amination (Fig. 2, A and B).
The kinetics of in vivo 99mTc-DMSA renal uptake in wild-type
(Clcn5Y/) mice increased progressively to a plateau level of
10% of the injected dose 5 h after injection (Fig. 2C; Table 1).
The interassay variation coefficient (5.6%) demonstrated highly
reproducible uptake measurements. Coronal and transverse sec-
tions evidenced the accumulation of 99mTc-DMSA in the cortex
of Clcn5Y/ kidneys, insensitive to furosemide (Fig. 2, D and E).
In contrast, the cortical uptake of 99mTc-DMSA was abolished in
Clcn5Y/ kidneys (Fig. 2, C and E; Table 1), with minimal
activity in the pelvis that was cleared after furosemide injection.
These results demonstrate that 99mTc-DMSA SPECT imag-
ing is able to delineate the functional renal cortex in the mouse,
with a 1-mm spatial resolution and a kinetics of uptake
similar to the asymptotic curve observed in humans. Defective
99mTc-DMSA cortical imaging is observed in cases of defec-
tive perfusion (kidney infarction) or generalized dysfunction of
PT cells (Clcn5Y/ mice).
Dynamic renography with 99mTc-MAG3. 99mTc-MAG3 is
considered as the best tracer for dynamic imaging of the
kidney. The tracer is concentrated in PT cells by basolateral
uptake, followed by secretion into the urine without intracel-
lular metabolization. The effect of anesthesia on the 99mTc-
MAG3 uptake by wild-type (C57) mice is shown on Fig. 3.
Ketamine-xylazine anesthesia induced a significant delay in the
99mTc-MAG3 clearance, with a delayed and higher peak of
uptake, as well as a higher degree of variability than in
conscious mice. The dynamic renography in conscious Clcn5
mice is shown on Fig. 4.
The SPECT imaging of 99mTc-MAG3 handling by wild-type
Clcn5Y/ kidneys is characterized by a rapid extraction from
blood (T1/2IN, 0.4  0.1 min), maximal renal accumulation
between 90 and 120 s after iv injection (12% of injected
dose/kidney), and subsequent tubular secretion (T1/2OUT, 4.7
0.5 min). Of note, the kinetic parameters of 99mTc-MAG3
handling are not significantly affected in Clcn5Y/ mice (Fig.
4; Table 1).
Renal handling of 123I-2-microglobulin in Clcn5 mice.
2-microglobulin is a 12-kDa protein that is ultrafiltrated and
completely reabsorbed via receptor-mediated endocytosis at
the apical pole of PT cells. Monitoring the endocytic uptake of
2-microglobulin is thus considered as a faithful marker of the
activity of PT cells (7). The dynamic SPECT imaging of
123I-2-microglobulin handling by wild-type Clcn5Y/ kidneys
showed a rapid glomerular filtration followed by a progressive
accumulation in the cortex, with maximal activity (6.4  0.7%
of injected dose/kidney) at 7 min postinjection (Fig. 5A; Table
1). The efficient breakdown of 123I-2-microglobulin in PT
cells was reflected by 123I reflux into the blood. The 123I
Table 1. Quantification by SPECT of proximal tubule
functions in Clcn5 mice
n Clcn5Y/ Clcn5Y/ P Value
99mTc-DMSA
Uptake, %ID/kidney 8 9.8 0.4 0.4  0.1 0.01
99mTc-MAG3
T1/2IN, min 6 0.4 0.1 0.4  0.1 NS
T1/2OUT, min 6 4.7 0.5 4.2  1.2 NS
123I-2-microglobulin
Tmax, min [6.75; 7.25] [1.75; 3] 0.01
Uptake7 min, %ID/kidney 6 6.4 0.7 0.5  0.2 0.01
Values are means  SD. n, No. of kidneys from 4 (3) pairs of Clcn5 mice.
SPECT, single proton emission-computed tomography; 99mTc-DMSA, 99mTC-
dimercaptosuccinic acid; %ID, % of injected dose; 99mTc-MAG3, 99mTc-
mercaptoacetyltriglycine; T1/2 IN, extraction from blood; T1/2OUT, tubular se-
cretion; Tmax, maximal renal accumulation; NS, not significant. Unpaired
Student’s t-test was used to compare Clcn5Y/ and Clcn5Y/ mice.
Fig. 3. Effect of anesthesia on 99mTc-MAG3 uptake in C57 mice. Dynamic
SPECT imaging in 2 conscious mice (black and red lines matching the 4
kidneys) shows a rapid extraction of 99mTc-MAG3 from blood (T1/2IN, 0.4 
0.1 min), a maximal renal accumulation 120 s after iv injection (15% of
injected dose/kidney), and subsequent tubular secretion (T1/2OUT, 3.1  0.3
min). Variability coefficients for T1/2IN and T1/2OUT are 6.6 and 9.3%, respec-
tively. In contrast, ketamine-xylazine anesthesia in 2 mice (blue symbols for
the 4 kidneys) induces a significant delay in 99mTc-MAG3 clearance (T1/2OUT,
21.1  9.0 min), as well as a higher variability for T1/2IN (54.0%) and T1/2OUT
(45.2%).
Fig. 4. Dynamic SPECT imaging of 99mTc-MAG3 uptake in Clcn5 mice. The
time-activity curve shows the rapid uptake of 99mTc-MAG3 in the kidney
cortex (T1/2IN, 0.4 0.1 min; variability coefficient, 12.2%), resulting from the
blood flow and the concentration by PT cells. The peak (maximal accumula-
tion: 11.7  1.6% of injected dose/kidney) occurs between 90 and 120 s after
iv injection, i.e., when excretion overcomes influx. The subsequent down-
sloping curve corresponds to the tubular secretion and elimination into the
urine (T1/2OUT, 4.7  0.5 min; variability coefficient, 9.1%; n 	 6 kidneys
from 3 pairs of Clcn5Y/ and Clcn5Y/ littermates). The spontaneous washout
is slightly faster in Clcn5Y/ mice (blue squares) than in wild-type Clcn5Y/
mice (red circles).
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present in Clcn5Y/ urine at 60 min postinjection was mostly
free iodine (92  2% of total urine activity, n 	 3). In strong
contrast, Clcn5Y/ kidneys showed a severe defect in the
reabsorption of ultrafiltrated 123I-2-microglobulin (Fig. 5A;
Table 1), with predominant urinary loss of intact 123I-2-
microglobulin (62  4% of total urine activity, n 	 3). The
autoradiography of kidneys fixed 7 min after injection of
125I-2-microglobulin, performed sequentially in the mice used
for in vivo SPECT imaging, showed a strong cortical signal in
Clcn5Y/ kidneys contrasting with the lack of tracer uptake in
Clcn5Y/ kidneys (Fig. 5B). Importantly, the calculated glo-
merular filtration rate of 125I-2-microglobulin (0.22  0.02
ml/min), based on the first part of the curve (see Fig. 5A), was
similar in both strains of Clcn5 mice. These data demonstrate
that the congenital PT dysfunction caused by the lack of ClC-5
is adequately reflected by SPECT imaging of defective renal
handling of 2-microglobulin.
Renal uptake of 123I-2-microglobulin: recovery after cis-
platin injury. We used a model of reversible tubular toxicity
induced by cisplatin, to test the potential of SPECT to provide
a longitudinal assessment of acquired PT dysfunction in indi-
vidual mice. The PT dysfunction, evidenced by the urinary
excretion of albumin (and that of CC16, data not shown),
peaked at day 5 and showed progressive recovery thereafter
(Fig. 6A). A similar profile was observed by sequential SPECT
Fig. 6. Cisplatin-induced acute kidney injury: albuminuria and 123I-2-micro-
globulin handling. Shown are serial determination of the urinary excretion of
albumin (A) and repetitive SPECT imaging of 123I-2-microglobulin uptake in
mice treated with cisplatin (B). The urinary excretion of albumin (baseline:
0.06  0.04 g/mg creatinine) peaked at day 5 (165  70 g/mg creatinine)
and subsequently decreased toward normal values at day 11 (2.5  1 g/mg
creatinine) and day 13 (3.8  3.2 g/mg creatinine) (*P  0.05, at least 4
values/time point). ns, Not significant. Representative sequential SPECT im-
aging for 123I-2-microglobulin handling in control mice (red circle) and a
cisplatin-treated mouse reveals defective endocytic uptake at day 5 (blue
inverted triangle), with partial recovery at day 12 (blue triangle). Note that the
excretion defect (curve 7 min) persists at day 12.
Fig. 5. Dynamic renal handling of 2-microglobulin in Clcn5 mice. The
time-activity curves show the progressive uptake of 123I-2-microglobulin
following glomerular filtration and apical, receptor-mediated endocytosis by
PT cells. The first part of the ascending curve corresponds to the progressive
accumulation of the tracer in the urinary lumen (i.e., glomerular filtration),
whereas accumulation beyond the first 3 min corresponds to apical endocytosis
by PT cells. A: dynamic SPECT analysis 123I-2-microglobulin in Clcn5Y/
(red circle) and Clcn5Y/ (blue cross) whole kidneys, and Clcn5Y/ cortex
(blue square). The curves show the average of 6 kidneys (3 pairs of mice) in
each group. In Clcn5Y/ mice, 123I-2-microglobulin rapidly accumulates in
the cortex, with subsequent washout corresponding to breakdown and further
release of free 123I into the blood. In Clcn5Y/ mice, 123I-2-microglobulin
rapidly clears through the kidneys as a pure result of glomerular filtration.
B: representative distribution of iodine-labeled 2-microglobulin in transverse
kidney sections at 7 min postinjection in Clcn5Y/ and Clcn5Y/ mice: in vivo
SPECT imaging vs. autoradiography. In Clcn5Y/ kidney, 2-microglobulin is
restricted to the cortex by SPECT, correlating with a segmental distribution
along radial proximal tubules. In Clcn5Y/ mice, SPECT only detects activity
in the pelvis without significant uptake in the cortex, as confirmed by the lack
of autoradiographic signal. Dotted circles represent the cortical contours in
Clcn5Y/ kidney. Bars 	 5 mm (left) and 1 mm (right).
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imaging for the renal uptake of 123I-2-microglobulin in indi-
vidual mice, with a major defect of uptake at day 5 followed by
partial recovery at day 12 (Fig. 6B).
DISCUSSION
This report demonstrates the feasibility and validity of both
static and dynamic SPECT imaging to investigate specific PT
functions in conscious mice. To the best of our knowledge, this
is the first report of dynamic SPECT renography in conscious
mice demonstrating the feasibility of continuous monitoring of
drug handling from the time of iv injection.
Our studies of 99mTc-MAG3 showed a delayed tracer clear-
ance and wider intra-assay variability in anesthetized mice,
confirming the adverse impact of ketamine/xylazine on base-
line renal function (14, 21, 22, 29). To circumvent the need for
anesthesia, we used a simple plastic holder, which was suffi-
cient to immobilize the mice without discomfort during SPECT
acquisition (Supplemental Fig. 1). The imaging of conscious
mice allowed us to sequentially use three radiotracers to assess
distinct PT functions in the same mice: 1) uptake of 99mTc-
DMSA to evaluate the functional cortex with high resolution;
2) dynamic 99mTc-MAG3 SPECT to investigate the basolateral
capture and apical secretion; and 3) processing of 123I-2-
microglobulin to assess apical receptor-mediated endocytosis.
We took advantage of the Clcn5 KO mice (7, 18, 28) to provide
a proof of concept for the use of SPECT, which showed a
severe defect in both apical receptor-mediated endocytosis and
basolateral anionic uptake, without significant alteration of the
apical secretion by PT cells.
The renal uptake of 99mTc-DMSA showed a progressive
accumulation in mouse kidney cortex, matching standard
curves reported in humans (16). At the plateau phase, 99mTc-
DMSA SPECT yields a millimetric delineation of the cortex,
sufficient to identify a local area of parenchymal damage, as
documented by the experimental infarction model (Fig. 2, A
and B). The procedure has a low interassay variability, which
supports its usefulness for repetitive and long-term biodistri-
bution studies, as well as longitudinal studies (e.g., evaluation
of toxicity following treatment) in the same mice.
The dynamic SPECT quantification of 2-microglobulin
renal uptake provided the first in vivo time course of PT
receptor-mediated endocytosis in conscious mice. The radio-
labeled LMW protein is freely filtered by the glomeruli, avidly
captured in the renal cortex, and rapidly degraded with subse-
quent release of the radiotracer and residual peptide/amino
acids to peritubular capillaries (2). The compartmental analysis
of 123I-2-microglobulin biodistribution (Supplemental Fig. 2)
enabled us to determine a GFR of 0.22  0.02 ml/min, similar
to that reported previously by using FITC-inulin clearance
(20). The usefulness of SPECT to evaluate PT function is
further demonstrated by the Clcn5 KO mice, characterized by
defective endocytosis due to the internalization of the multili-
gand receptors, megalin and cubilin (7, 18). Our data show that
the defective PT apical endocytosis previously evidenced by ex
vivo counting (7) is confirmed by noninvasive in vivo SPECT
of 123I-2-microglobulin uptake. Despite similar GFR, the
tubular reabsorption of 123I-2-microglobulin is strongly im-
paired in Clcn5Y/ mice, with altered metabolization in PT and
subsequent loss in the urine, mostly as native 123I-labeled
protein.
Similarly to 2-microglobulin, the renal handling of 99mTc-
DMSA has been regarded as an indicator of PT dysfunction in
human and animal models (1, 25). For example, treatment of
rats with Na-maleate induces a typical renal Fanconi syn-
drome, with marked reduction of 99mTc-DMSA uptake (19). In
our study, SPECT quantification of 99mTc-DMSA capture
shows that inactivation of Clcn5 is associated with a lack of
tracer accumulation in the renal cortex, suggesting a severe
defect in PT basolateral function. It is likely that the residual
signal detected in the pelvis of Clcn5Y/ mice represents a
small glomerular filtration of 99mTc-DMSA (17). The basolat-
eral uptake of 99mTc-DMSA from peritubular capillaries into
S3 PT cells is mediated by the Na/dicarboxylate cotransporter
NaDC3 (SLC13A3) (4, 13) (Fig. 1). Of note, the coexpression
of nonconducting fragments of ClC-5 with NaDC transporters
alters their translation and/or trafficking in Xenopus laevis
oocytes, resulting in decreased surface expression (15). The
severe deficit in both apical and basolateral SPECT uptake
reported here further demonstrates that the functional loss of
ClC-5 induces a generalized intracellular trafficking in PT cells
(7, 18).
Renal scintigraphy with 99mTc-MAG3, a radiolabeled ana-
log of p-aminohippurate, can provide excellent image quality
even with severe renal failure (10). For instance, 99mTc-MAG3
imaging detected changes in renal function in anesthetized
mice as early as 5 h following ischemia-reperfusion injury
(22). A model for 99mTc-MAG3 secretion by PT cells has
recently been proposed, based on in vitro transport experiments
in X. laevis oocytes (24) (Fig. 1). 99mTc-MAG3 is intracellu-
larly accumulated through the basolateral organic anion trans-
porter OAT1 that is expressed in all PT segments (4). The
molecular counterpart of 99mTc-MAG3 apical transport could
involve the Na-dependent phosphate transporter NPT1 and/or
the multidrug resistance protein MRP2 (5, 24). Our results
demonstrate that PT dysfunction caused by the functional loss
of ClC-5 is not associated with a defect in 99mTc-MAG3 renal
handling. The contrast between the complete loss of 99mTc-
DMSA basolateral uptake and the preserved 99mTc-MAG3
secretion in Clcn5 KO kidneys provides further evidence that
these two pathways are functionally independent (24) and
corroborates immunolocalization studies showing a distinct
distribution of NaDC3 and OAT1 in PT segments (4). Addi-
tional SPECT studies using mouse models invalidated for
distinct organic anion transporters may help establish the
metabolic pathways handling these particular radiotracers, as
well as other drugs and metabolites.
In conclusion, SPECT analysis represents a new approach to
characterize the renal PT function in conscious mice, based on
acute and/or repetitive biodistribution studies using distinct
radiolabeled tracers. Two limitations cannot be ignored. First,
the spatial resolution of SPECT, being limited to the millimet-
ric range, cannot compete with rapidly evolving live-micros-
copy methods (6). Second, although SPECT offers a temporal
resolution of 5–10 s for pharmacokinetic studies, this may not
be sufficient to explore faster functions such as organelle
activation or intracellular trafficking. Nevertheless, the devel-
opment of creative approaches dedicated to small-animal im-
aging will permit further functional investigations of transgenic
mouse strains, with relevance for renal physiology or disease
mechanisms.
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